Cellectar Biosciences Stock Forecast

Sell candidate since Jun 01, 2026 Loss -7.74%

The Cellectar Biosciences stock price fell by -7.74% on the last day (Tuesday, 2nd Jun 2026) from $2.97 to $2.74. During the last trading day the stock fluctuated 8.03% from a day low at $2.74 to a day high of $2.96. The price has fallen in 4 of the last 10 days and is down by -12.74% for this period. Volume has increased on the last day by 92 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 238 thousand shares were bought and sold for approximately $653.44 thousand.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.60 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 4.29% during the next 3 months and, with a 90% probability hold a price between $2.71 and $3.73 at the end of this 3-month period.

CLRB Signals & Forecast

There are few to no technical positive signals at the moment. The Cellectar Biosciences stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $3.06 and $2.98. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 06, 2026, and so far it has fallen -22.38%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Cellectar Biosciences gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Cellectar Biosciences stock

Cellectar Biosciences finds support from accumulated volume at $2.68 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.220 between high and low, or 8.03%. For the last week, the stock has had daily average volatility of 6.39%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CLRB) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect Cellectar Biosciences to open at $2.81, and during the day (based on 14 day Average True Range), to move between $2.61 and $2.87, which gives a possible trading interval of +/-$0.255 (+/-9.76%) up or down from last closing price. If Cellectar Biosciences takes out the full calculated possible swing range there will be an estimated 9.76% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.68 (2.19%) than the resistance at $3.10 (13.14%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cellectar Biosciences stock A Buy?

The Cellectar Biosciences stock holds several negative signals and despite the positive trend, we believe Cellectar Biosciences will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.598 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 3, 2026 - $2.81 ( 2.68%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk